首页 | 本学科首页   官方微博 | 高级检索  
检索        

阿魏酸川芎嗪对缺血再灌注大鼠心肌细胞凋亡及凋亡相关蛋白表达的影响
引用本文:赵润英,郝伟,孟祥军,赵丽妮,李昭,马明洋,丁双双,魏巍.阿魏酸川芎嗪对缺血再灌注大鼠心肌细胞凋亡及凋亡相关蛋白表达的影响[J].中国病理生理杂志,2013,29(12):2139-2143.
作者姓名:赵润英  郝伟  孟祥军  赵丽妮  李昭  马明洋  丁双双  魏巍
作者单位:1沈阳医学院药理教研室,机能实验中心,药物研究中心,辽宁 沈阳 110034;2中国医科大学2011级11班,辽宁 沈阳 110001; 3沈阳博瑞生物技术有限公司,辽宁 沈阳 110014
基金项目:沈阳市科技计划项目(No.F10-149-9-16)
摘    要: 目的:观察阿魏酸川芎嗪对缺血再灌注损伤大鼠心肌细胞凋亡的影响,并探讨其可能机制。方法:将60只雄性SD大鼠随机分成5组:(1)假手术组;(2)缺血再灌注组;(3)川芎嗪(4 mg/kg)组;(4)阿魏酸川芎嗪低剂量(4 mg/kg)组;(5)阿魏酸川芎嗪高剂量(8 mg/kg)组。采用结扎左冠状动脉前降支30 min、再灌注120 min的方法复制大鼠心肌缺血再灌注模型;各组大鼠于再灌注前10 min分别颈静脉注射给药,于再灌注结束后,进行血清生化及心肌组织学检测。结果:阿魏酸川芎嗪能显著降低心肌缺血再灌注损伤大鼠血清中肌酸激酶同功酶、乳酸脱氢酶、心肌钙蛋白I和丙二醛的水平,提高总超氧化物歧化酶活性,增加心肌Bcl-2蛋白的表达,减少心肌Bax蛋白的表达, 提高Bcl-2/Bax 的比值和降低心肌细胞凋亡指数,与缺血再灌注组比较,差异有统计学意义(P<0.01)。阿魏酸川芎嗪各项指标优于川芎嗪(P<0.05或P<0.01)。结论:阿魏酸川芎嗪能减轻大鼠心肌缺血再灌注损伤;其抗缺血再灌注诱导的心肌细胞凋亡的机制可能与其上调Bcl-2蛋白和下调Bax蛋白表达有关。

关 键 词:阿魏酸川芎嗪  心肌缺血  再灌注损伤  细胞凋亡  Bcl-2蛋白  Bax蛋白  
收稿时间:2012-05-14

Effects of ligustrazine ferulate on myocardial apoptosis and apoptosis-related protein expression in rats with myocardial ischemia-reperfusion injury
ZHAO Run-ying,HAO Wei,MENG Xiang-jun,ZHAO Li-ni,LI Zhao,MA Ming-yang,DING Shuang-shuang,WEI Wei.Effects of ligustrazine ferulate on myocardial apoptosis and apoptosis-related protein expression in rats with myocardial ischemia-reperfusion injury[J].Chinese Journal of Pathophysiology,2013,29(12):2139-2143.
Authors:ZHAO Run-ying  HAO Wei  MENG Xiang-jun  ZHAO Li-ni  LI Zhao  MA Ming-yang  DING Shuang-shuang  WEI Wei
Institution:1Department of Pharmacology, Center for Functional Experiment, Center for Drug Research, Shenyang Medical College, Shenyang 110034, China; 2Class 11, Grade 2011, China Medical University, Shenyang 110001, China; 3Shenyang Borey Biotechnology Limited Company, Shenyang 110014, China. 
Abstract:AIM:To observe the effects of ligustrazine ferulate on the apoptosis of myocardial cells in rats with myocardial ischemia-reperfusion injury, and to explore its possible mechanism. METHODS:Sixty male SD rats were randomly divided into five groups: sham-operation group, ischemia-reperfusion group, ligustrazine (4 mg/kg) group, low-dose (4 mg/kg) ligustrazine ferulate group and high-dose (8 mg/kg) ligustrazine ferulate group. The rat myocardial ischemia-reperfusion model was established by 30 min of myocardial ischemia followed by 120 min of reperfusion. Drugs were administered to the rats by jugular vein injection 10 min before reperfusion. After the reperfusion was finished, the biochemical indicators in serum and the histological indexes in myocardium were detected. RESULTS: Compared with ischemia-reperfusion group, ligustrazine ferulate lowered the serum levels of creatine kinase MB form, lactate dehydrogenase, cardiac troponin I and malondialdehyde, elevated the activity of total superoxide dismutase in serum and the expression of Bcl-2 protein in myocardium, decreased the expression of Bax protein and myocardial apoptotic index, and increased the Bcl-2/Bax ratio (all P<0.01). All the indicators in ligustrazine ferulate groups were dose-dependently superior to those in ligustrazine group (P<0.05 or P<0.01). CONCLUSION: Ligustrazine ferulate protects rats against myocardial ischemia-reperfusion injury. Its anti-apoptotic effect may be related to up-regulation of Bcl-2 and down-regulation of Bax.
Keywords:Ligustrazine ferulate  Myocardial ischemia  Reperfusion injury  Apoptosis  Bcl-2 protein  Bax protein
点击此处可从《中国病理生理杂志》浏览原始摘要信息
点击此处可从《中国病理生理杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号